EMA Authorised: Zyprexa Velotab (olanzapine) — CHEPLAPHARM Registration GmbH

View source ↗

Summary

The EMA authorised Zyprexa Velotab, a generic olanzapine product, under CHEPLAPHARM Registration GmbH for schizophrenia and bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Zyprexa Velotab (olanzapine)

Snippet

Status: Authorised. Therapeutic area: Schizophrenia;Bipolar Disorder. MAH: CHEPLAPHARM Registration GmbH. Decision date: 16/12/2024